Begin main content

Call for Patient Input and Clinical Experts: Contrave

March 28, 2019
CADTH has received the following notice(s) of pending drug submission(s).  Brand name Contrave Generic name naltrexone hydrochloride and bupropion hydrochloride Manufacturer Bausch Health, Canada Inc. Indication(s) Chronic weight management in adults Project Number SR0610-000 Call for patient input 2019-03-28 Patient input deadline 2019-05-17 Su...

CADTH Celebrates Health Technology Assessment Leaders

March 28, 2019
Ottawa, ON (March 28, 2019) — CADTH is pleased to celebrate outstanding and ongoing achievements in the field of health technology assessment (HTA) by announcing the recipients of the 2019 CADTH Recognition Awards. In addition to honouring two individuals who have made significant contributions to the field of HTA in Canada, 10 Anniversary Medal...

Call for Nominations Now Open for CADTH Advisory and Expert Committees

March 18, 2019
CADTH is seeking nominations for its advisory and expert committees. If you have significant expertise in the Canadian health care system, are interested in helping support health care decision-makers in making informed choices about health technologies, and are passionate about ensuring that the Canadian health care system is the best it can be...

New at CADTH - March 2019

March 8, 2019
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.